Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum MEDRELEAF CORP T.LEAF

"MedReleaf Corp is engaged in the production and sale of cannabis for medical purposes as regulated by the ACMPR, pursuant to its Licences and, in particular, its Markham Commercial Licence."

Bullboard (TSX:LEAF)

View:
Post by Signalcatcheron May 06, 2018 7:31pm

# of patients?

Anyone know how many patients Leaf has?
Post by JTDOUBLEon May 05, 2018 10:18pm

GWPH or LEAF!!

Both in Medical MJ .. Gwph 5 bucks 2013 now 140 US!! Leaf just 2x since the IPO !! Potentials: many catalysts as Canada recreational..  Any offers is below 30 bucks is a slap on us ...more  
Comment by KLownHouSERon May 05, 2018 5:36pm

RE:This stock is worth 12$ not 23$

Look at shares out and market cap.  Greenthumb trying to scare you out of your gold. Or he’s actually a moron.
Post by JTDOUBLEon May 04, 2018 7:16pm

Apotex ??

Leaf we do not know yet but it talking to big 3 LP .. Weed might be picture as they entrench their medical side..  Aph still needed to catch up with M&A with money coming off US sales of ...more  
Comment by telecaster_400on May 04, 2018 5:42pm

RE:RE:RE:RE:RE:Morningstar Quant Rept. Values LEAF at $31.60

except that Aurora was still in Toronto last night. And likely had tickets to the game supplied by LEAF. Probably just needed to tie up some loose ends today before heading home for the weekend. My ...more  
Comment by Buckshot26on May 04, 2018 3:23pm

RE:RE:RE:RE:RE:RE:Morningstar Quant Rept. Values LEAF at $31.60

God are you dumb.  They have 100,000 sq ft indoor in Markham, 200, 000 sq ft indoor in Bradford and are currently retrofitting 1m sq ft of greenhouse.  I mention the first 300,000 square ...more  
Comment by BirchBrookon May 04, 2018 3:19pm

RE:RE:RE:RE:RE:Morningstar Quant Rept. Values LEAF at $31.60

Leaf only has 23,000 sq/ft of growing space to date. Gonna need great deal of dillution to finish what they started. No wonder they are looking to sell.
Comment by Buckshot26on May 04, 2018 3:11pm

RE:RE:RE:RE:Morningstar Quant Rept. Values LEAF at $31.60

Yep, I fully expect the deal to be consumated this weekend and announced Monday AM.  The twist is I think it will be with Canopy not Aurora.  Bruce is too smart to let this opportunity slip ...more  
Comment by BirchBrookon May 04, 2018 3:04pm

RE:RE:RE:RE:Morningstar Quant Rept. Values LEAF at $31.60

Yeah they valued WEED @ 51 $ and it dropped to 25.50
Post by BirchBrookon May 04, 2018 2:58pm

This is about to take a nasty drop

up over 3 $ since Monday, bye bye. 
Comment by Buckshot26on May 04, 2018 1:38pm

RE:RE:Morningstar Quant Rept. Values LEAF at $31.60

With regards to why they want to sell. The answer is too much money made. MedReleaf was structured differently then most if not all the other LP deals.  What I mean is they did not go the RTO ...more  
Comment by Skunkworks1on May 04, 2018 12:16pm

RE:RE:Good thing ACB offer didn't go through!!

Yes.  Unfortunately you are probably right.  A buyout through WEED would be alot more appealing.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities